The event will highlight ongoing basic, translational, clinical and population studies addressing the biological mechanism, management and prevention of breast cancer. Researchers from participating institutions will share their exciting work with a goal to develop cross-institutional collaborations.
The keynote speaker will be Helen Piwnica-Worms, professor in the Department of Experimental Radiation Oncology in the Division of Radiation Oncology at University of Texas MD Anderson Cancer Center. Piwnica-Worms, whose research focuses on identifying alterations with functional significance to the development and progression of breast cancer, will present, “Tackling Resistance in Triple-negative Breast Cancer.”
Other speakers at the symposium include experts from Case Comprehensive Cancer Center, University of Pittsburgh, The Ohio State University, West Virginia University, and Cleveland Clinic.
Program topics covered will include:
- Therapeutics-response resistance;
- Survivorship and disparities;
- Cancer cell biology; and
- Microenvironment and immunology.